Brief: Eurobio Scientific FY Core Business Revenues Up At EUR 130 Mln
10/04/2024 16:55
April 10 (Reuters) - Eurobio Scientific SA ALERS.PA :
* 2023 ANNUAL RESULTS
* FY FREE CASH FLOW OF EUR 26.4 MLN
* END-FY NET FINANCIAL DEBT REDUCED TO EUR 5.5 MLN, WITH EUR
89
MLN CASH POSITION
* FY CORE BUSINESS REVENUES UP 39% TO EUR 130 MLN
* NET PROFIT FOR 2023 WAS EUR 4.8M.
* NET FINANCIAL DEBT REDUCED TO EUR 5.5 MLN, WITH EUR 89 MLN
CASH
POSITION
* FY ADJUSTED EBITDA EUR 27.3 MLN VERSUS EUR 40.5 MLN YEAR
AGO
* FY OPERATING RESULT EUR 10.1 MLN, DOWN VERSUS EUR 30.8 MLN
YOY
Source text for Workspace: ID:nGNE4rTKXz
Further company coverage: ALERS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 785 110;))
Recent news on Eurobio Scientific SA
See all newsBrief: Eurobio Scientific EB Development Files Public Offer For Shares
Brief: Eurobio Scientific Says At End Of June 2024, Recorded Revenues Of 73.4 Mln Euros, Compared With 59.1 Mln Euros A Year Ago
Brief: Eurobio Scientific FY Core Business Revenues Up At EUR 130 Mln
Brief: Eurobio Scientific Cancels 694,300 Treasury Shares, Representing Around 6.34% Of Share Capital
Brief: Eurobio Scientific H1 Ebitda Up To EUR 13.4 Million